Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1295 Pancreatic Neoplasms 818 Carcinoma, Hepatocellular 782 Stomach Neoplasms 753 Rectal Neoplasms 565 Esophageal Neoplasms 452 Colonic Neoplasms 414 Esophageal Squamous Cell Carcinoma 277 Neoplasm Metastasis 263 Cholangiocarcinoma 251 Liver Neoplasms 219 Neoplasms 200 Biliary Tract Neoplasms 179 Adenocarcinoma Of Esophagus 139 Gastrointestinal Stromal Tumors 108 Gallbladder Neoplasms 96 Adenocarcinoma 94 Breast Neoplasms 91 Gastrointestinal Neoplasms 89 Carcinoma, Non-Small-Cell Lung 87 Bile Duct Neoplasms 69 Sarcoma 67 Lung Neoplasms 64 Ovarian Neoplasms 60 Anus Neoplasms 59 Melanoma 54 Uterine Cervical Neoplasms 52 Carcinoma 48 Digestive System Neoplasms 45 Prostatic Neoplasms 40

Interventions

trifluridine tipiracil drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × First-line Treatment × Gastrointestinal × Clear all

NCT05077839 2021-10-25

TOBACO

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Gastrointestinal

First-line Treatment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡